Galantamine is an FDA-approved acetylcholinesteraseinhibitor used to treat mild-moderate Alzheimer's disease.
2
Donepezil is a potent and selective acetylcholinesteraseinhibitor developed for the treatment of Alzheimer's disease.
3
Elevating acetylcholine with the acetylcholinesteraseinhibitor physostigmine induces depression symptoms in people and increases FST immobility in mice.
4
We sought to explore whether acetylcholinesteraseinhibitor (AChEI) therapy ameliorates clinical symptoms in AD through down-regulation of inflammation.
5
Nowadays, the first-line treatment for AD is the application of acetylcholinesteraseinhibitors.
6
Design: Secondary analyses of stroke patients who received acetylcholinesteraseinhibitors during inpatient rehabilitation.
7
An electrophoretically mediated microanalysis technique was developed for the rapid screening of acetylcholinesteraseinhibitors.
8
Design, synthesis and evaluation of new acetylcholinesteraseinhibitors by combining quinolinecarboxamide to a benzylpiperidine moiety are described.
9
However, acetylcholinesteraseinhibitors are basically anti-symptomatic for a limited aspect of AD pathology and are associated with serious side-effects.
10
Interventions: Secondary analysis of patients receiving inpatient stroke rehabilitation care plus random assignment to one of two acetylcholinesteraseinhibitors or no drug at rehabilitation admission.